The University of Queensland

Investigating the efficacy of intratumoral delivery of immune checkpoint inhibitors in epithelial ovarian cancer (2018–2020)

Grant type:

AstraZeneca Pty Ltd

Researchers:

• 

  Honorary Professor John Hooper

  Honorary Professor
  

  Mater Research Institute-UQ

  Faculty of Medicine

Funded by:

AstraZeneca Pty Ltd